NBCD and Prosoft Clinical enter acquisition-agreement under the Sanos Group

February 1, 2021

Prosoft Clinical (Prosoft), a full-service CRO specialized in dermatology based in Wayne, PA, USA and NBCD, a global full-service CRO specialized in osteoarthritis, based in Copenhagen, Denmark have entered into an agreement to share resources with the potential for a future merger under Sanos Group. Prosoft Clinical has a strong US presence, and capabilities that in addition to classic CRO services include a proprietary electronic data capture (EDC) system, and specialty focus on dermatological products and biostatistics. NBCD’s global full-service CRO capabilities provide a strong European- and Asian presence as well as a well-recognized specialty within clinical studies in osteoarthritis, where NBCD is considered a leading CRO.

Under the agreement, NBCD will take an initial ownership position in Prosoft with the intent of a full acquisition. The two companies will jointly manage global clinical development programs. The combination of NBCD and Prosoft resources allows the joint organization to further strengthen its operations in global clinical studies especially within the specialty areas of dermatology and osteoarthritis.

Jeppe Ragnar Andersen, CEO of NBCD and Sanos Group, stated: “This is a major milestone for us. We are conducting several global studies with good US presence, and this transaction will further strengthen our US capabilities and, together with Prosoft’s dermatological expertise, allow us to add additional value to our clients in both osteoarthritis and dermatology in the USA, Europe and Asia.”

Bob Babilon, President of Prosoft, commented: “We are excited to partner with NBCD to form this extraordinary global organization, which allows us to readily serve our clients across many regions. With a history of excellence in providing the full range of clinical trial services in different indications, particularly in osteoarthritis and dermatology, we expect to become a leader in our specialty therapeutic areas.”

About Prosoft Clinical

Prosoft Clinical is a contract research organization focused on pharmaceutical product design and development. Since 1995, Prosoft has been providing services to the pharmaceutical, biotech, and medical device industries primarily within dermatology, immunology and allergy. The team has a longstanding track record of excellence in bringing products to market and experience in US FDA regulatory representation.

For more information on the capabilities of Prosoft Clinical, please visit our web site at ProsoftClinical.com or contact us.

About NBCD A/S

NBCD, formerly known as Nordic Bioscience Clinical Development, is dedicated to clinical drug development, specializing in osteoarthritis. Having worked 25+ years in biomarker development and clinical trials, NBCD has acquired extensive expertise in rheumatology, in particular within osteoarthritis, where NBCD is a scientific and operational leader.

For more information on the capabilities of NBCD, please visit our web site at nbcd.com or contact us.

About Sanos Group A/S

Sanos Group is a contract research organization headquartered in Herlev, Denmark, consisting of NBCD A/S and Sanos Clinic A/S. Sanos Group provides its clients clinical trial management and conduct of phase 1 to 4 trials offering both CRO services through NCBD and ProSoft Clinical in osteoarthritis and dermatology and/or access to dedicated clinical research centers with a broader therapeutic focus to other CRO, Biotech and Pharma clients.

For inquiries, contact Jeppe Ragnar Andersen, CEO of Sanos Group (jra@sanosclinic.com) or Bob Babilon, President of Prosoft Clinical (b.babilon@prosoftclinical.com)